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Bacteria produce some of the most potent biomolecules known, of which many cause serious diseases
such as tetanus. For prevention, billions of people and countless animals are immunised with the highly
effective vaccine, industrially produced by large-scale fermentation. However, toxin production is often
hampered by low yields and batch-to-batch variability. Improved productivity has been constrained by a
lack of understanding of the molecular mechanisms controlling toxin production. Here we have devel-
oped a reproducible experimental framework for screening phenotypic determinants in Clostridium
tetani under a process that mimics an industrial setting. We show that amino acid depletion induces
production of the tetanus toxin. Using time-course transcriptomics and extracellular metabolomics to
generate a ‘fermentation atlas’ that ascribe growth behaviour, nutrient consumption and gene expression
to the fermentation phases, we found a subset of preferred amino acids. Exponential growth is char-
acterised by the consumption of those amino acids followed by a slower exponential growth phase
where peptides are consumed, and toxin is produced. The results aim at assisting in fermentation me-
dium design towards the improvement of vaccine production yields and reproducibility. In conclusion,
our work not only provides deep fermentation dynamics but represents the foundation for bioprocess
design based on C. tetani physiological behaviour under industrial settings.
© 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Clostridium tetani, the causative agent of tetanus, is an important
pathogen of humans and animals. The disease occurs when a
wound is infected with vegetative cells or spores which then pro-
duce an extracellular neurotoxin (tetanospasmin or TeNT) that
blocks inhibitory neurotransmitters in the central nervous system
[1]. To date, much of the research on C. tetani has been focussed on
the mechanism of TeNT [2e6]. More extensive research has been
restricted by the absence of reproducible culturing conditions and
genetic tools to allow for the study of this organism at the molec-
ular level. To compound this, vaccines are so effective thatin).
r Ltd. This is an open access articleunderstanding the organism has not been required to manage
disease burden [7].
Worldwide, billions of people and countless companion and
production animals are protected from tetanus by immunisation
with highly effective TeNT toxoid vaccines. Despite its importance,
the current fermentation processes have advanced little since the
1970s. While not reported in scientiﬁc literature, industrial TeNT
production is hampered by low titres and occasional batch failures
(communication, Zoetis Inc.). TeNT is produced from C. tetani cul-
tures grown under classical batch fermentation conditions. At the
end of the fermentation, after ~150 h, the active toxin is harvested
from the culture supernatant. The toxin is subsequently inactivated
with formalin before it is mixed with other components for use in
multivalent vaccines. The medium used for TeNT production is
critical and typically consists of peptides from digested casein, soy
or occasionally other plant derived peptones, which are inherently
of inconsistent quality. In addition, during medium formulation,under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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modiﬁcations such as calcium precipitation [8e10] and Maillard
reactions [11] which exacerbate the variability in yields. Critically, it
remains unclear which components of themedium are essential for
toxin production and even the fundamental reason(s) for the
organism to produce toxin.
Attempts to improve TeNT production using traditional rational
process engineering approaches have had limited success [12]. Fed-
batch processes that increase cell density and TeNT production
have not been transferred to the commercial settings, while at-
tempts to rationally design medium have resulted in reduced TeNT
production [13]. To improve TeNT production, it is imperative to
better understand the biology of C. tetani under industrial condi-
tions; apart from the isolated example that links the tetanus toxin
precursor gene, tetX, expression to the regulator tetR [14], little is
known about C. tetani physiology and TeTN production elicitors.
Typically, toxin production in clostridia is a highly regulated and
complex molecular process [15]. In the case of TeNT, the gene
encoding TeNT (tetX) must not only be expressed and translated,
but the resulting proto-toxin (pTeNT) must also undergo proteo-
lytic cleavage before the toxin becomes active [16]. Analysis of tetX
expression and regulation, and TeNT production and maturation
has been heavily reliant on comparative analysis with Clostridium
botulinum and Clostridium perfringens.
To address the challenges associatedwith TeNT production, here
we have performed a systematic study of the behaviour of C. tetani
during bioreactor fermentations for the production of TeNT using a
multi-dimensional biological analysis. Systems biology has been
widely adopted for the study of model organisms such as yeast and
E. coli [17] however, it is not widely used for the study of non-model
organisms. Here we performed an in-depth time-course analysis of
the fermentation that deﬁnes nutrient consumption and a 15 time-
point transcriptomics proﬁle dataset to provide a detailed ‘tran-
scriptional fermentation atlas’ of the process. We have identiﬁed
distinct growth phases and attribute mechanisms to explain the
complex life cycle of C. tetani in bioreactors, which are tightly
controlled through complex growth phase switches at the tran-
scriptional and translational level. At the molecular level, three
'transcriptional stages' were identiﬁed. We believe that this
research will underpin future improvements to the production of
TeNT and contribute to our global understanding of the central
metabolic regulation, pathogenicity, and life cycle of C. tetani under
industrial conditions.
2. Results
The ﬁrst step for bioprocess optimisation is the establishment of
constant environmental conditions to maintain high reproduc-
ibility. To achieve high toxin yields, C. tetani needs to be fermented
using a complex process under a tightly controlled environment. As
opposed to our initial attempts in which large batch to batch
variability with poor active toxin recovery was observed in ﬂask
fermentations, bioreactors provided highly reproducible results
(Fig. 1A).
2.1. C. tetani's growth displays two exponential growth phases:
exponential I and exponential II
After establishing reliable fermentations, we sampled the fer-
menters frequently so as to uncover a previously uncharacterised
exponential growth phase followed by a second phase of lower
growth rate (Fig. 1A). The fermentation begins with a period of
exponential growth (Stage I), characterised by rapid production of
biomass (m ¼ 0.24 ± 0.006 h1), a decrease in pH and an increase in
dissolved oxygen (DO) (Fig. 1C) (from 0 to 4.5%) when air is passedthrough the headspace. Ten hours after the start of the fermenta-
tion, cells transition to Stage II, which is characterised by a slower
growth rate (m ¼ 0.083 ± 0.005 h1) for the next 30 h. Growth rates
were determined by dry cell weight (DCW) and optical density
(OD). During this stage, pH increases to a peak of 7.2 after 25 h of
the fermentation start, while DO concentrations remain stable.
During Stage III (40 he70 h) cells undergo a phase of autolysis. At
this time, dramatic increases in both pH and DO are observed with
pH rising from 7.2 to 8.0 and DO increase from 5% to 70%. Stage IV is
the ﬁnal period of toxin maturation in which the proto-toxin in the
supernatant becomes biologically active. Although pTeNT must be
in the supernatant following autolysis, the concentration of active
toxin does not peak until 120 h, some 48 h after complete lysis is
observed.
To characterise the biological process for TeNT production at the
molecular level, fermenters were sampled regularly during the four
growth stages (Fig. 1). Given the inﬂuence of medium composition
in TeNT production yields and the lack of data supporting its design,
we used a systems biology driven approach to understand the
physiological program that governs the behaviour of the C. tetani
population during fermentation. To this end, time course samples
were taken for analysis of medium component consumption,
namely free amino acids and vitamins (Fig. 1D and E), metal ions,
and casein-derived peptides (Fig. 2A and B). Results were mapped
to the fermentation proﬁle to generate a physiological fermentation
atlas. It is important to note that due to the inherent nature of the
fermentation in complex medium results from the repetitions are
similar but not identical. This is particularly true for the proteomics
study and for the RNA-seq repeats. Variations are likely due to
variability in the proteins digestion prior to MS analysis and the
inherent nature of the complex fermentations (see for example ph
and pO2 proﬁle for 5 replicates in Fig. 1C). For clarity and simplicity,
most results will focus on the ﬁne kinetic fermentation (the one
that contains 15 time points) while results from both fermentations
are presented in the ﬁgures and described in the text.
2.2. Growth on free amino acids
The transition from the Stage I to Stage II is associated with a
depletion of a subset of free amino acids from themedium (Fig. 1D).
Analysis examining nutrient consumption indicated complete or
almost complete (<10% remaining) consumption of glutamic acid,
aspartic acid, asparagine, threonine, serine, histidine, and tyrosine.
The fastest decrease in amino acid concentration occurs between
the 11 h and 13 h, particularly for histidine, glutamic acid, threo-
nine, and serine. Aspartic acid and asparagine were consumed
between 10 h and 20 h and tyrosine was consumed after 30 h.
Interestingly, depletion of amino acids correlates with the transi-
tion from Stage I to Stage II. Contrarily, the concentration of Ile, Pro
and Val increased along the fermentation presumably due to the
activity of extracellular peptidases (Supplementary Figs. 1 and 2).
To investigate the nutritional dependence of casein-derived
peptides in the fermentation, cells were fermented in a chemi-
cally deﬁned medium containing the 20 proteinogenic amino acids
plus hydroxy-L-proline, cystine [18] and glucose. The chemically
deﬁned medium supports growth at m ¼ 0.69 h1 despite no
glucose being consumed. When using the chemically deﬁned me-
dium, cells stop growing after the depletion of aspartate, aspara-
gine, glutamate, serine, histidine, methionine, leucine, lysine,
arginine, threonine and glutamine while no toxin production was
observed conﬁrming the importance of casein peptides and amino
acid metabolism in the C. tetani fermentation (Supplementary
Fig. 3). Further gene expression analysis conﬁrmed that the gene
encoding for tetX is essentially not transcribed in CDM (data not
shown).
Fig. 1. Characterisation of the bioreactor growth and toxin production during C. tetani fermentation. A) Growth characteristics from ﬁve independent experiments. The four
phases of the fermentation are indicated: exponential growth phase I (Stage I, dashed red), exponential growth phase II (Stage II, dashed blue), autolysis (Stage III, dashed green) and
toxin maturation (Stage IV, dashed cyan). B) Concentration of tetanus toxin (TeNT [ﬂocc units]) detected in ﬁve independent fermentation supernatants measured approximately
120 h after inoculation. C) pH and pO2 proﬁles along the fermentation from ﬁve independent experiments D) Temporal dynamics of the free amino acids consumed by C. tetani in
bioreactor fermentations. Ala, Arg, Gly, Ile, Leu, Lys, Phe, Pro, Trp, Val were not included in the plot as they are not consumed. The concentration of Val, Ile and Pro increases along
the fermentation (Supplementary Fig. 2) probably due to peptidase activity. The HPLC quantiﬁcation method used was unable to quantitate Cys. Error bars represent the standard
deviation (SD) of the mean. E) Consumption of vitamins during C. tetani fermentation. The data for amino acid and vitamin concentration are represented as percentage of the
starting material. Error bars represent the standard deviation (SD) of the mean. Amino acids and metabolomics data represents a typical fermentation run. (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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After consuming free amino acids during Stage I, cells consume
peptides from casein in complex medium triggering the onset of
expression of the tetX gene (Supplementary Fig. 4). Quantitative
proteomics was used to identify the peptides consumed during this
stage in two independent fermentations. It is important to note that
result vary between the 2 biological replicates, likely due to vari-
ations during trypsin digestion of the casein prior to LCMS or due to
lot to lot variability in media preparation. Using this approach, we
detected consumption of ﬁve peptides (VPQLEIVPN, VYPFPGPI,
VYPFPGPIPN, KVPQLEIV and YQEPVLGPV) and (KVPQLEIVPN,
TQTPVVVPPFLQPEV, TDAPSFSDIPNPI, VYPFPGPIPN and
SLPQNIPPLTQTPV). In the ﬁrst fermentation, consumption dy-
namics showed that peptide VPQLEIVPN is consumed between 8 h
and 18 h, KVPQLIEV is consumed between 8 h and 25 h and pep-
tides YQEPVLGPV, VYPFPGPI and VYPFPGPIPN are consumed be-
tween 25 h and 32 h of the fermentation, while in the second
biological replicate the peptide KVPQLEIVPN and
TQPVVVPPFLQPEV are consumed ﬁrst (Fig. 2A and B). While pep-
tide consumption and growth behaviour are uncorrelated events, it
would appear that the presence of speciﬁc peptides is essential for
activation of key cellular programs such as the production of TeNT.2.4. Role of key vitamins, minerals and glucose on the fermentation
Casein provides more than just peptides; at a minimum, vita-
mins, minerals and trace metals are also present in casein. To
measure their inﬂuence in growth behaviour and toxin production,
a subsection of nutrients added to the medium were also moni-
tored for consumption using LC-MS/MS (Fig. 1E). From this analysis,
10 metabolites were measured. From those, L-cystine, calcium
pantothenate, and riboﬂavin were consumed during stage I of the
fermentation. Pyridoxine hydrochloride and nicotinic acid accu-
mulate in themedium. Interestingly, uracil was both consumed and
produced during the fermentation. Given that iron (Fe2þ and Fe3þ)
is an essential element for both metabolic and pathogenic func-
tions, extracellular and intracellular iron were also quantiﬁed. Iron
in the medium seemed to be in excess, so no signiﬁcant changes
were observed during the fermentation time course; however,
intracellular total iron (Fe2þ and Fe3þ) slightly decreased during the
second stage of the fermentation.
Other medium components, including glucose and zinc, were
also monitored. Only 30% of the glucose is consumed in the ﬁrst
75 h and zinc levels were relatively stable during the ﬁrst and
second stages of the fermentation and peaked upon completion of
lysis.
Fig. 2. Relative consumption of the most consumed peptides from casein during
C. tetani fermentation. Peptide consumption marks the onset of Stage II of the
fermentation. The consumption of similar peptides is shown in these ﬁgures however,
due to abundant sites for trypsin activity it is unlikely to obtain the same peptides for
proteomics analysis.
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fermentation and TeNT production
Unlike the transition between Stage I and II, there is no clear
mechanism that can be linked to the transition into Stage III. No
correlation was observed between the transition to Stage III and
environmental factors such as temperature, dissolved oxygen,
redox potential or pH. Remarkably, autolysis was consistently
observed 2.3 biomass doubling times after the end of Stage II,
irrespective of the initial inoculum and the biomass reached at
stage I. This strongly suggests that the onset of autolysis is physi-
ologically determined; therefore, in order to investigate the mo-
lecular events underpinning autolysis and toxin production we
analysed the transcriptome across the fermentation time course.2.6. Transcriptomic analysis of the C. tetani fermentation
The in-depth transcriptional analysis was performed to monitor
genome-wide transcriptional events from 15 time-points across
Stage I and II (Fig. 3A). Transcriptional data were initially assessedby Principal Component Analysis and a clear time-related variance
pattern was deﬁned by principal component one (Supplementary
Fig. 5A). Subsequently Partial Least Squares/Projection to Latent
Structures (PLS) analysis (Supplementary Fig. 5B) and Orthogonal
PLS (Fig. 3B) were applied to the data to correlate deﬁned growth
stages with transcriptional events across the fermentation. These
analyses permit the identiﬁcation of genes (or groups thereof) that
have patterns of expression related to the fermentation time
course. For more information relating to these multivariate
methods please refer to [19] and [20]. To better understand the
physiological conditions driving the various growth stages, tran-
scriptional events linked to the central metabolic pathways and
virulence cellular programs were analysed (Fig. 3C).
2.7. Central carbon and energy metabolism
The transcriptional analysis shows that Stage I and II concern
primarily ATP generation from amino acid catabolism or peptide
degradation. Speciﬁcally, genes related to the transport of serine/
threonine (ctc02307), tyrosine (ctc00819), branched chain amino
acid (ctc02088) and, D-alanine glycine (ctc01172) were signiﬁcantly
expressed during Stage I. Similarly, sodium/glutamate symport
carrier protein (ctc02306) was expressed during the Stage II.
Amongst genes coding for enzymes involved in amino acid degra-
dation, the gene for tyrosine phenol-lyase (ctc00818) showed high
expression during late Stage I and throughout Stage II. In addition,
threonine dehydratase (ctc02624), L-allo-threonine aldolase
(ctc01037) and serine dehydratase (alpha and beta subunits,
ctc01981 and ctc01982, respectively) coding genes were expressed
at Stage I reaching a maximum at Stage II. Remarkably, the gluta-
mate degradation genes methyl-aspartate mutase (mutS, mutE and
mutL) together with their transcriptional regulator (ctc02569) were
only signiﬁcantly expressed during Stage I, decreasing in expres-
sion towards the middle of Stage II. Lastly, the formiminoglutamase
coding gene (ctc01812), involved in histidine metabolism, was only
signiﬁcantly expressed during early Stage I while aspartate kinase
coding gene (ctc02356) was only seen to be expressed during Stage
II.
Aminotransferases were also signiﬁcantly expressed along the
fermentation time course. For example, serine-pyruvate/aspartate
aminotransferase (ctc00695) rapidly increased its expression in
Stage I and then rapidly decreased at the onset of Stage II.
Contrarily, the aspartate aminotransferase (ctc01294) and amino-
transferase genes (ctc01359) had rapid expression during the ﬁrst
7 h. High expression of four peptidases, namely glutamyl-
endopeptidase precursor (ctc00612), zinc carboxypeptidase
(ctc00519), leucyl-aminopeptidase (ctc01866) and putative amino-
peptidase encoded in the plasmid pE88 (ctp20) were also observed
during the stage II of the fermentation.
In the pathway for biosynthesis of pyrimidines, the aspartate
carbamoyltransferase gene (ctc02383) decreased its expression
levels at the end of Stage I but increased rapidly by mid- Stage II.
Similar expression patterns were observed for uracil phosphor-
ibosyltransferase (upp) and the gene encoding the bifunctional
pyrimidine regulatory protein PyrR uracil phosphoribosyltransfer-
ase (pyrR). In the purine biosynthetic pathway, the amidophos-
phoribosyltransferase gene (ctc01965), an enzyme from de novo
synthesis of purines, showed signiﬁcant expression during Stage I
and II, whereas the phosphoribosyl-formylglycinamidine synthase
II gene (ctc01029) was only signiﬁcantly expressed during Stage I.
Finally, the genes coding for phosphoribosylaminoimidazole
carboxylase catalytic subunit (ctc01966), phosphoribosylamine-
glycine ligase (ctc01961) and phosphoribosyl-aminoimidazole
synthetase (ctc01964) were evenly expressed along the
fermentation.
Fig. 3. Overview of the transcriptional molecular map of the C. tetani fermentation A) In-depth transcriptional analysis was performed to monitor genome-wide transcriptional
events from 15 time-points across the exponential and linear growth phases. RNA-seq data was performed for samples extracted at the times represented by circles, squares,
triangles an upside down triangles. The RNA-seq data clusters together in the OPLS analysis by 4 transcriptional clusters as illustrated in B and C. B) Orthogonal Partial Least Squares
(OPLS) analysis correlates the growth stages previously deﬁned with 4 transcriptional clusters across the fermentation. Samples from the early stage (6.5 h and 7.5 h) (circles),
cluster together. Samples from 8.5 to 13 h (squares), 18e23 h (triangles) and samples 33e52.5 h (upside down triangles) cluster together. Separation of classes is maximised through
the predictive component (X-axis), intraclass variability is described through the component (Y-axis). Axis values are arbitrary and relate to the scores derived from the linear
combinations of the variables for each observation, providing two-dimensional x and y coordinates for the multivariate data. C) Heat map displaying physiological conditions
illustrating the different growth clusters for selected genes clustering near tetX; transcriptional events linked to the central metabolic pathways and virulence cellular programs
were analysed in depth in Figs. 3e5.
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Three ferrous iron transport coding genes (ctc00451-00452 and
ctc00534) were expressed during Stage I and II (Fig. 4A and Fig. 5A).
The gene encoding for the iron (III) di-citrate transport system
permease protein FecD/HmuV (fecD) and the gene coding a hemin
transport system ATP-binding protein (fecE) were notably higher
after the beginning of Stage II and throughout Stage III (Figs. 4B and
5B).
Additionally, Stage I of the fermentation was characterised by
high transcription for genes associated with the rnf complex, which
drives the ATPase synthase in C. tetani (Figs. 4C and 5C). The genes
associated with ATP synthesis, particularly those linked to (V)-type
ATPase synthase (ctc02326-02328, and ctc02331) (Figs. 4D and 5D)
were largely transcribed during Stage I and II whereas a ﬂagellum-
speciﬁc ATP synthase (ctc01673) (Figs. 4E and 5E) was transcribed
manly during Stage I. ATPase genes, such as calcium transporter
ATPases (ctc01647, ctc02043 and ctc02330) were highly expressed
during mid-Stage II (Figs. 4F and 5F).2.9. Virulence factors and other related cellular programs
Transcription of genes related to virulence factors were alsoexamined. Genes encoding for an internalin A-type protein
(ctc00494-00495), putative PAF acetylhydrolase (ctc00594) and the
adhesin encoding gene slpA/cwp66 (ctc00491) showed increased
expression during the ﬁrst 10 h of the fermentation (Stage I) (Fig. 6A
Fig. 7A). Conversely, a subset of adhesion related encoding genes
(ctc00767, ctc00769, and ctc00770-00772) was highly expressed
during Stage II of the fermentation (20 h) (Fig. 6C Fig. 7C). A
distinctive expression pattern was observed for a gene encoding a
periplasmic immunogenic protein (ctc01814); this gene showed
decreasing expression towards the end of Stage I reaching its lowest
value at 12 h, followed by a subsequent increased expression to-
wards mid-late Stage II (Fig. 6B Fig. 7B). Remarkably, a subset of
genes of the operon for ethanolamine uptake and degradation
(ctc02163, ctc02165, ctc02168, ctc02170, and ctc02174) showed very
similar patterns of expression (Fig. 6B Fig. 7B).
While sigma factor expressionmight be a response to regulatory
mechanisms strictly dependent on the fermentation conditions,
sporulation-related sigma factors (ctc01125, ctc01126, and ctc01128)
were expressed during Stage II of the fermentation (Fig. 6D Fig. 7D).2.10. Expression of the TeNT encoding plasmid pE88
The high-resolution transcriptional map of the fermentation
Fig. 4. Time course gene expression proﬁle of genes belonging to iron and ATP related metabolic genes along the C. tetani fermentation. Transcript levels are expressed in
normalized fragments per kilobase per million (FPKM) A) ferrous iron transport related genes ctc00451-ctc00452 and ctc00534 B) di-citrate transport system permease coding
gene fecD/hmuV and hemin transport system ATP-binding protein (fecE) C) the Rnf Complex rnfA-D and rnfG, D) (V)-type ATP synthase coding genes ctc02326-02328 and ctc02331 E)
ﬂagellum-speciﬁc ATP synthase coding gene ctc01673 and F) calcium transporter ATPase coding genes (ctc01647, ctc02043 and ctc02330).
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plasmid pE88. Expression levels of the gene encoding TeNT (tetX)
and its transcriptional regulator tetR steadily increased (Fig. 8).
Interestingly, two genes encoding for hypothetical proteins (ctp02
and ctp03) showed the same expression proﬁle to tetR. Other reg-
ulatory genes with relevant expression patterns during the
fermentation were two putative sigma factors, encoded by ctp10-
11; however, their expression constantly increased during the ﬁrst
stage of the fermentation reaching a maximum expression at 20 h.
We did not ﬁnd signiﬁcant expression of the gene encoding the
virulence factor collagenase T (colT).3. Discussion
Traditional bioprocess optimisation has historically focussed on
the improvement of microbial fermentation performance (i.e.
biomass yields and ﬁnal product titres), largely ignoring physio-
logical understanding. For example, most of the industrial culture
medium formulations include cost convenient carbon sources such
as glucose, ignoring the fact that more suitable carbon sources
could reduce undesired metabolic/physiologic effects. While
developing inexpensive bioproducts is the biochemical engineer's
primary goal, a compromise should be met between cost efﬁciency
and physiological optimality for bioprocess design. Recent ad-
vances in omics technologies have made it possible to correlatemicrobial dynamic growth behaviour with transcriptional and
protein expression events across the fermentation. In this study, we
used a systems biology platform to correlate transcriptional events
with transitional growth stages during C. tetani fermentation for
TeNT production. Wewere able to identify the importance of amino
acid metabolism in energy generation and biomass production.
Given the nature of the complexmedium used, biological replicates
do notmatch perfectly. In fact results are similar but not identical in
many cases.
Guided by transcriptomics data, the metabolic pathways for
serine transport and degradation through L-serine dehydratase and
threonine dehydratase leading to the production of pyruvate were
mapped. Similarly, the degradation of threonine via; 1) the L-allo-
threonine aldolase producing glycine and acetaldehyde or; 2) the
threonine dehydratase producing ammonia and 2-oxobutanoate
were identiﬁed. The data shows that the high expression of the
tyrosine phenol-lyase gene (responsible for the conversion of
tyrosine into phenol, pyruvate, and ammonia) supports the previ-
ous assumptions that C. tetani produce indole from aromatic amino
acid degradation [21]. Despite these observations, it still remains
unknown whether alternative tyrosine degradation pathways are
active in C. tetani as previously reported for colonic bacteria [22].
Despite the fact that it is historically known that histidine
degradation leads to the formation of glutamate via urocanate in
C. tetani [23], only formiminoglutamase, the gene coding for the last
Fig. 5. Time course gene expression proﬁle of genes belonging to iron and ATP related metabolic genes along the C. tetani fermentation (biological replicate). Transcript
levels are expressed in normalized fragments per kilobase per million (FPKM) A) ferrous iron transport related genes ctc00451-ctc00452 and ctc00534 B) di-citrate transport
system permease coding gene fecD/hmuV and hemin transport system ATP-binding protein (fecE) C) the Rnf Complex rnfA-D and rnfG, D) (V)-type ATP synthase coding genes
ctc02326-02328 and ctc02331 E) ﬂagellum-speciﬁc ATP synthase coding gene ctc01673 and F) calcium transporter ATPase coding genes (ctc01647, ctc02043 and ctc02330).
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expressed during Stage I of the fermentation. Subsequent degra-
dation of glutamate is likely to occur via the mesaconate pathway.
The data shows that the transcriptional regulator for the methyl
aspartate mutase cluster (glutamate mutase) is highly transcribed,
suggesting that glutamate is catabolised tomesaconate through the
cobamide-dependent pathway. While similar results were
observed for Clostridium tetanomorphum [24], supernatant analysis
from Clostridium sticklandii fermentations indicated accumulation
of glutamate [25].
Asparagine degradation, although experimentally observed,
could not be linked to any speciﬁc metabolic pathway. Tran-
scriptomic data did not show signiﬁcant expression of the L-
asparaginase coding gene at any time-point of the fermentation
highlighting our lack of metabolic understanding in C. tetani. This
result shows the strong need for a functional annotation of the
C. tetani genome based on omics observations (Fig. 9).
Given the importance of complex peptide mixtures (e.g. casein
or peptone digests) for the biosynthesis of toxin in clostridium
species, we analysed peptide consumption during C. tetani fer-
mentations. Once a subset of free amino acids is consumed, pep-
tides are degraded. An energy costly peptide transporting system is
likely to be the cause of the change in growth rate from Stage I into
Stage II. Similar data has been reported in casein degrading bacteria
such as Streptococcus thermophilus. Our data shows that ﬁve casein-derived peptides are preferentially consumed. Interestingly, these
peptides contain a Pro-Phe-Pro domain which has been previously
reported to act as a zinc-protease inhibitor [26,27]. We consider
this particularly interesting as the tetanus toxin is a zinc metal-
loprotease and thus, it is possible that C. tetani consume these
peptides to block the degradation of the toxin or the activity of
other zinc metalloproteases [27].
RNA-seq data shows that the expression of tetX and tetR is
almost undetectable while the cells are consuming free amino
acids. This was also observed when cells grew on chemically-
deﬁned medium (Supplementary Fig. 3); tetX and tetR expression
increases dramatically as the cells transition from the consumption
of free amino acids into the consumption of peptides. Tran-
scriptomics conﬁrmed that the regulator of toxin production (tetR)
follows the same expression proﬁle as the toxin (tetX) [28], along
with most of the genes encoded in the plasmid and several genes
linked to sporulation and this over-expression is triggered by amino
acid depletion.
The homology between the botulinum and tetanus toxins sug-
gests that they have evolved from a common ancestor. However,
despite their similarity, little is known about their regulation.
Moreover, BoNT toxins can be produced by different C. botulinum
strains (serotypes from groups I to IV) with slightly different
metabolic patterns and toxin regulation, whereas TeNT is produced
by a homogenous group C. tetani [3]. Toxin production in both
Fig. 6. Transcriptional proﬁle of genes related to pathogenic cellular programs along the C. tetani fermentation. Transcript levels are expressed in normalized fragments per
kilobase per million (FPKM). A) internalin A-type protein (ctc00494-00495), putative PAF acetylhydrolase (ctc00594) and adhesin encoding gene slpA/cwp66 (ctc00491); B)
periplasmic immunogenic enconding gene ctc01814 and ethanolamine uptake and degradation genes (ctc02163, ctc02165, ctc02168, ctc02170 and ctc02174); C) adhesion encoding
genes (ctc00767, ctc00769, ctc00770-00772); D) sporulation-related sigma factors (ctc01125, ctc01126 and ctc01128).
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tion of the medium. High levels of arginine, proline or glutamate in
minimal medium were detrimental for the production of BoNT in
C. botulinum Hall A and Okra B whereas the supplementation with
casein increased toxin titres [29]. This seems to be also the case of
C. tetani which consume neither arginine nor proline, in fact, pro-
line accumulates in the medium across the fermentation. Equally, a
high concentration of tryptophan lowered BoTN titre in
C. botulinum serotype E while casein presence in the medium
stimulated toxin production [30]. Glycine seems to have a stimu-
latory effect on the production of toxin in C. botulinum serotype F
[31] whereas is required neither in C. botulinum serotype A nor in
C. tetani. Since amino acids preference seems to be different in each
organism, it is difﬁcult to assess the nutritional requirements that
govern the toxin production mechanism. Both species, however,
can produce more toxin when casein is available in the medium. It
is important to note that toxin regulation is not only linked to
environmental signals but a more complex network where two
component systems, small regulatory RNAs, quorum sensing, and
environmental signals work together and interspecies correlations
between our observations in C. tetani may be relevant to work in
C. botulinum but need to be interpreted with extreme care as both
systems are divergent in both toxin regulation and nutritional
requirements.
As in other pathogens, the regulation, synthesis, and secretion of
the toxin is tightly controlled by regulatory elements that aresensitive to environmental signals. Despite the enormous avail-
ability of nutrients (casein and sugar copiously available in stage IV
of the fermentation), cells perform autolysis, a suicidal and seem-
ingly non-intuitive event given the abundance of nutrients avail-
able at this stage of the process. Construction of the ﬁrst molecular
fermentation atlas for one of the most pharmaceutically relevant
members of the clostridium family, is the ﬁrst step towards
the understanding of toxin biosynthesis under conditions far
different from native environment. Thus, we state that a
physiology-driven design of a TeNT production process in C. tetani
is a plausible way for improving process outcomes and will have an
impact on vaccine availability for humans and livestock, impor-
tantly some of our observations may be relevant to close relatives
such as C. botulinum.
4. Materials & methods
4.1. Bacterial strain, growth and fermentation conditions
Clostridium tetani strain E88 was purchased from ATCC. Unless
otherwise speciﬁed, all chemicals were purchased from Sigma
(Sigma Aldrich, NSW, Australia). Seed medium 29.8 g/L of Fluid
Thioglycolate (Difco, Franklin Lakes, New Jersey, USA) the inoculum
seed was 500 ml and they were grown for 18 h at 37 C. Fermen-
tation culture medium was prepared as speciﬁed in Mueller and
Miller [10] with the adjustments made by Latham et al. [9] plus the
Fig. 7. Transcriptional proﬁle of genes related to pathogenic cellular programs along the C. tetani fermentation (biological replicate). Transcript levels are expressed in
normalized fragments per kilobase per million (FPKM). A) internalin A-type protein (ctc00494-00495), putative PAF acetylhydrolase (ctc00594) and adhesin encoding gene slpA/
cwp66 (ctc00491); B) periplasmic immunogenic enconding gene ctc01814 and ethanolamine uptake and degradation genes (ctc02163, ctc02165, ctc02168, ctc02170 and ctc02174); C)
adhesion encoding genes (ctc00767, ctc00769, ctc00770-00772); D) sporulation-related sigma factors (ctc01125, ctc01126 and ctc01128).
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Biotin, 0.375 mg/L Riboﬂavin, Thiamine, Pyridoxine hydrochloride,
and nicotinic acid; 1.5 mg/L calcium pantothenate, 0.000075 mg/L
vitamin B12, 1.875mg/L uracil, 0.03 mg/L FeCl3 and N-Z-Casein. The
culture medium was autoclaved at 121 C for 18 min. The chemi-
cally deﬁned medium was prepared as described in Ref. [18].
Samples were extracted from three different fermentations
performed in 4 Multifors Infors HT bioreactors or Sartorius at
working volumes of 1 and 5 L, respectively. The temperature was
controlled at 35 C throughout the fermentation. Initial anaerobic
conditions were obtained by bottom sparging the mediumwith N2.
Post inoculation, the N2 gassing was changed to the overlay at a rate
of 340ml/min. Four hours after the inoculation, N2was switched off
and air was gassed into the fermenter from the overlay at a rate of
340 ml/min until the end of the fermentation.4.2. Analytical methods
Extracellular components such as free amino acids were quan-
tiﬁed as described in Ref. [32]. Central carbon metabolites were
measured using an ion pairing HPLC-MS/MS method, as described
in Ref. [33] andmodiﬁed in Ref. [34]. Proteomic discovery (IDA) and
quantiﬁcation (SWATH) samples were ﬁrst separated using a Shi-
madzu Prominence nano-LC system as previously described in
Ref. [35] using the modiﬁcations reported by Ref. [36]. For vitamins,
HPLC Grade acetonitrile and acetic acid (AR Grade) was purchased
from RCI Labscan (Bangkok, Thailand) and Labscan (Gliwice,Poland), respectively. Deionised water was generated via an Elga
Purelab Classic water puriﬁcation unit (Veolia Water Solutions and
Technologies, Saint Maurice Cedex, France). Liquid
chromatography-tandem mass spectrometry (LC-MS/MS) data was
acquired on a Dionex UltiMate 3000 liquid chromatography system
(Dionex, California, USA) coupled to an ABSciex 4000 QTRAP mass
spectrometer (ABSciex, Concord, Canada). The liquid chromatog-
raphy system was controlled by Chromeleon software (v6.80 SR9,
Dionex), and chromatographic separation was achieved by inject-
ing 10 mL onto a Gemini-NX C18 150 mm  2 mm I.D., 3 mm 110 Å
particle column (Phenomenex, Aschaffenburg, Germany) equipped
with a pre-column Security Guard Gemini-NX C18 4 mm  2 mm
I.D. cartridge. The column oven temperature was controlled and
maintained at 55 C throughout the acquisition and the mobile
phases, adapted from Refs. [37], were as follows: 7.5 mM aqueous
tributylamine adjusted to pH 4.95 (±0.05) with glacial acetic acid
(eluent A) and acetonitrile (eluent B). The mobile phase ﬂow rate
was maintained at 300 mL/min throughout the gradient proﬁle
(Supporting Table 2) and was introduced directly into the mass
spectrometer with no split. The mass spectrometer was controlled
by Analyst 1.5.2 software (ABSciex) and was equipped with a Tur-
boV electrospray source operated in negative ion mode. The
following optimised parameters were used to acquire scheduled
Multiple Reaction Monitoring (MRM) data: ionspray
voltage 4500 V, nebulizer (GS1), auxiliary (GS2), curtain (CUR)
and collision (CAD) gases were 60, 60, 20 and medium (arbitrary
units), respectively. The auxiliary gas temperature was maintained
Fig. 8. A and B show heat maps for all genes encoded in the pe88 Plasmid. As shown in the heat-map, most genes encoded in the plasmid display a similar transcriptional proﬁle
as the genes tetX and tetR in both fermentations.
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Fig. 9. Central carbon metabolic pathways for C. tetani. The Fig illustrates the pathways involved in amino acid transport, catabolism and ATP metabolism. tetX and tetR
expression increase dramatically as the cells transition from the consumption of free amino acids into the consumption of peptides, showing that amino acids catabolism plays a key
role in virulence in C. tetani.
C. Licona-Cassani et al. / Anaerobe 41 (2016) 113e124 123at 350 C. For all analytes the entrance potential (EP) was 10 V.
The samples were run with sample- and analyte-relevant calibra-
tion standards and pooled QC samples [38,39] to control for
reproducibility of data acquisition and to ensure data integrity.
Analyte stock solutions were prepared in puriﬁed water (Veolia)
and aliquots of each solutionweremixed to achieve a ﬁnal calibrant
solution at 50 mM. This calibrant solution was serially diluted and
the dilutions used as calibration standards from 50 to 0.195 mM,
constituting 5  x  9 calibration points to account for differential
responses in the mass spectrometer. As an internal standard, 1 ml of
a 1 mM aqueous solution of azidothymidine was added to 99 mL of
sample. Data were processed using MultiQuant 2.1 software
(ABSciex).
SWATH samples were prepared as speciﬁed in Ref. [40]. Brieﬂy,
50 mg of caseinwas diluted in 800 mL of 8M urea/50mMAMBIC and
loaded into four Amicon Ultra-0.5 ml centrifugal ﬁlters with
nominal cut-off of 30,000 Da (Millipore). Protein samples were
washed twice with 200 mL of 8 M urea/50 mM AMBIC by centri-
fugation (14,000 g for 15 min), followed by two washes in 100 mL of
50mMAMBIC. In-ﬁlter trypsin digestionwas performed (overnight
at 37 C, 50 rpm) using 5 mg of MS-grade trypsin (Promega) in 30 mL
of AMBIC (50 mM). Digested proteins were collected by three
rounds of centrifugation with 30 mL of AMBIC (50 mM). Final pH of
the samples was adjusted to 3 using formic acid, concentratedusing a vacuum centrifuge, and ﬁnally concentrated using a C-18
ZipTip (Millipore) to assure equal quantities were injected in each
LC injection. Information-Dependent Acquisition (IDA) was used to
generate a reference library from a pooled sample that included
50 mg of proteins from each of time points across the fermentation
in two biological replicates. In order to avoid column overloading,
C-18 ZipTips were used. Prior to MS analysis, samples were
concentrated using a vacuum centrifuge to remove residual
acetonitrile (ACN) and resuspended in 99.5 mL of 0.1% formic acid.
Synthetic peptide mixture (HRM calibration kit from Biognosys)
was spiked to each sample for retention time shift correction ac-
cording to [41]. IDA and SWATH injections were injected by
duplicate from 4 mg of peptides and from 0.5 mg of peptides,
respectively.
4.3. RNA isolation, mRNA enrichment, RNASeq sequencing
Total RNAwas extracted from C. tetaniwith RNeasy midi column
as per manufacturer’s instructions plus the addition of a mechan-
ical disruption through a bead beating step and the off-column
DNase I treatment. RNA quality was evaluated using BioAnalyzer
(Agilent) and Nanodrop 1000 (Thermo Scientiﬁc). Ribosomal RNA
was removed using the ribo-zero meta-bacterial kit (Epicentre).
mRNA libraries for sequencing were prepared using TruSeq RNA
C. Licona-Cassani et al. / Anaerobe 41 (2016) 113e124124sample preparation kits from Illumina. All sequencing was per-
formed at the University of Queensland on the Illumina Hiseq-
2000.
4.4. Transcriptomic analysis
Reads were aligned to the genome using TopHat [42], with two
mismatches allowed per read alignment. Before mapping to the
genome the 100 bp reads were trimmed to 75 bp to avoid reading
errors. Transcript abundance was estimated using FPKM from cuf-
ﬂinks [43] using classic-FPKM normalisation, CuffDiff was used to
estimate differentially expressed proteins. A log2-fold change of þ
2 or - 2 and 0.05 false discovery rate was used to estimate signiﬁ-
cant changes. Transcript data were also assessed globally by Prin-
cipal Component Analysis, and correlation with the fermentation
time course further analysed by Partial Least Squares/Projection to
Latent Structures (PLS) and Orthogonal PLS using SIMCA (version
13.0.3.0; MKS Umetrics AB, Umea, Sweden).
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